FDA Warning Letter — Bi-Coastal Pharma International
The FDA took a Warning Letter action against Bi-Coastal Pharma International on Jun 30, 2022 (Shrewsbury, NJ). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Bi-Coastal Pharma International
- Date
- Jun 30, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Center
- CDER
- Location
- Shrewsbury, NJ (United States)